Elicio Therapeutics, Inc.
ELTXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ELTX. That does not mean none is planned.
Get an email about ELTX's next catalysts
Track Elicio Therapeutics (ELTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
ELTX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.42 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ELI-002 7P | Phase 2 | Pancreatic Ductal Adenocarcinoma | - | - |
Frequently asked questions
What is in Elicio Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Elicio Therapeutics, Inc.'s (ELTX) pipeline across Phase 2. Its lead program is ELI-002 7P (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Elicio Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Elicio Therapeutics, Inc. (ELTX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ELTX biotech catalysts?→
Add ELTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Elicio Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.